Medication info
Ibandronate Sodium Tablets 150 mg (Ibandronate Sodium Monohydrate)

Ibandronate Sodium Tablets 150 mg (Ibandronate Sodium Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
Yuyu Pharmaceutical Co., Ltd.
Appearance
White to almost white oval film-coated tablet
Packaging
1 tablet (1 tablet/PTPX1)
Approval status
Active

MFDS item code 201207401 · Approved 2012.10.23 · Insurance code 644501860

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water, at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium) : - This medicine must be swallowed with a sufficient amount (180-240ml) of water while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - Do not chew or suck the tablet, to avoid esophageal ulcers. If a patient forgets to take the medicine on the regularly scheduled dosing day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the previously scheduled regular dosing day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled dosing day, and thereafter continue to take 1 tablet each month on the previously scheduled regular dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or more; use of this medicine is not recommended in patients with a creatinine clearance of less than 30mL/min because clinical experience is insufficient. Elderly No dose adjustment is necessary.
Child dose
Efficacy and safety in children 18 years of age or younger have not been studied.

Ingredients

Manufacturer
Yuyu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis in postmenopausal women to increase bone strength and reduce the risk of fractures. It helps prevent bone loss and improve bone health. When taken regularly, it can maintain or increase bone density, improving mobility in daily activities. Additionally, it is effective in alleviating pain and discomfort associated with osteoporosis. It serves as an important therapeutic agent for not only fracture prevention but also overall bone health management. Thus, it is used safely and effectively for managing osteoporosis in postmenopausal women.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water, at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium) : - This medicine must be swallowed with a sufficient amount (180-240ml) of water while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - Do not chew or suck the tablet, to avoid esophageal ulcers. If a patient forgets to take the medicine on the regularly scheduled dosing day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the previously scheduled regular dosing day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled dosing day, and thereafter continue to take 1 tablet each month on the previously scheduled regular dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is necessary Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or more; use of this medicine is not recommended in patients with a creatinine clearance of less than 30mL/min because clinical experience is insufficient. Elderly No dose adjustment is necessary.

Child dose

Efficacy and safety in children 18 years of age or younger have not been studied.

Precautions

This medication should not be administered to certain patients. For example, those with allergies to this drug or its components, untreated hypocalcemia, inability to sit or stand upright for more than 60 minutes, esophageal issues that impair swallowing, and those with lactose intolerance or related genetic disorders should not take this medication. Patients with severe renal impairment should use this medication with caution. Side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur while taking this medication. Serious side effects, including flu-like symptoms, eye inflammation, and osteonecrosis of the jaw, have also been reported in some patients. Before starting this medication, it is important to address hypocalcemia and bone and mineral metabolism issues and to ensure adequate intake of calcium and vitamin D. Additionally, since this drug can irritate the gastric mucosa, care should be taken in patients with gastrointestinal diseases such as esophagitis or gastritis. When taking this medication, you must remain sitting or standing upright for at least 60 minutes and avoid consuming food or medications containing calcium or iron simultaneously. It is advisable to avoid other foods or medications for one hour after taking the drug. Due to the risk of osteonecrosis of the jaw, it is recommended that cancer patients or those requiring dental treatment receive a dental examination prior to taking this medication and avoid excessive dental work during treatment. This medication is not recommended for use in pregnant or breastfeeding women, and safety has not been established in children under 18 years of age. In cases of overdose, gastrointestinal disturbances or hypocalcemia may occur; patients should take milk or antacids and should not induce vomiting, remaining upright. Lastly, store this medication out of reach of children, and properly dispose of expired medications in an environmentally safe manner.

Side effects

Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle spasms, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, worsening of asthma, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical femoral fracture, subtrochanteric femoral fracture, visual disturbances, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and kept at temperatures between 1°C and 30°C. Proper storage will help maintain its efficacy and prevent degradation.

Appearance and packaging

Appearance

White to almost white oval film-coated tablet

Package unit

1 tablet (1 tablet/PTPX1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.